VillageMD, the primary-care provider controlled by
Walgreens, which has a 63% stake in VillageMD, said it will invest $3.5 billion of debt and equity to support the combination and will remain the biggest shareholder in the combined company with a 53% stake after the deal closes, according to a statement Monday. Evernorth, a subsidiary of
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.